Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 2019Translational PediatricsOpen Access

Personalising medicine in inflammatory bowel disease—current and future perspectives

View Full Paper
Ask AI
Bookmark
Share

Authors

JAJames J. AshtonUniversity Hospital Southampton NHS Foundation TrustEMEnrico MossottoUniversity of SouthamptonSESarah EnnisUniversity Hospitals Birmingham NHS Foundation Trust

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Ashton et al. (2019) studied this question.

synapsesocial.com/papers/6a7d63ea2c686697de1cc67bhttps://doi.org/10.21037/tp.2018.12.03
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Grading of invasive breast carcinoma through Grassmannian VLAD encoding2017 · 107 citations
  2. 2Genetic factors conferring an increased susceptibility to develop Crohn's disease also influence disease phenotype: results from the IBDchip European Project2012 · 270 citations
  3. 3The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management2010 · 1,499 citations
  4. 4Regulatory T cells in inflammatory bowel disease2008 · 144 citations
  5. 5Autologous nonmyeloablative hematopoietic stem cell transplantation in patients with severe anti-TNF refractory Crohn disease: long-term follow-up2010 · 187 citations